comparemela.com

Seelos Therapeutics Announces the Selection of SLS-002 (intranasal racemic ketamine) for Inclusion in the U.S. Department of Defense's Adaptive Platform Trial to Evaluate Potential Treatments for Post-Traumatic Stress Disorder (PTSD)

Seelos Therapeutics Announces the Selection of SLS-002 (intranasal racemic ketamine) for Inclusion in the U.S. Department of Defense's Adaptive Platform Trial to Evaluate Potential Treatments for Post-Traumatic Stress Disorder (PTSD)

kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,Vietnam ,Republic Of ,Iraq ,New York ,Iraqi ,Americans ,Mike Moyer ,Anthony Marciano ,Raj Mehra ,Tim Whitaker ,Agency For Healthcare Research ,Nasdaq ,Exchange Commission ,Us Army Medical Department ,Brain Health Project Management Office ,Us Services ,Us Army Medical Research ,Defense Health Agency ,Lifesci Advisors ,Seelos Therapeutics Inc ,Us Special ,Department Of Defense ,Us Department Of Veterans Affairs ,Us Department Of Defense ,Us Army Medical Materiel Development Activity ,Treatment Program ,Javelin Pharmaceuticals Inc Hospira ,Drug Administration ,Prnewswire Seelos Therapeutics Inc ,Drug Treatment Program ,Warfighter Readiness ,Medical Materiel Development ,Chief Executive Officer ,Platform Trial ,Columbia Suicide Severity Rating Scale ,Chief Medical Officer ,Veterans Affairs ,World War ,Korean War ,Vietnam War ,Persian Gulf War ,Desert Storm ,Operations Iraqi Freedom ,Crisis Lifeline ,Acute Suicidal Ideation ,Major Depressive Disorder ,Post Traumatic Stress ,Javelin Pharmaceuticals ,Healthcare Research ,Medical Materiel Development Activity ,Medical Research ,Development Command ,Medical Department ,Joint Staff ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Sci Advisors ,

comparemela.com © 2020. All Rights Reserved.